黑人镰状细胞特质与镰状细胞病患者的肾功能下降:一项观察性队列研究
该多中心观察性队列研究纳入2005至2018年注册数据,比较黑人镰状细胞特质、镰状细胞病与正常血红蛋白表型患者的eGFR年变化。中位随访8年,校正后两种镰状细胞表型eGFR下降均快于参照组,且镰状细胞病快于特质;男性、糖尿病及基线eGFR≥90与更快下降相关。
要点
- 镰状细胞特质和镰状细胞病均与黑人患者eGFR下降更快相关。
- 镰状细胞病患者的eGFR下降速度显著快于镰状细胞特质患者。
- 男性、糖尿病和基线eGFR≥90 ml/min per 1.73 m2与两种表型更快eGFR下降相关。
核心结论
- 镰状细胞特质和镰状细胞病与黑人患者eGFR下降更快相关,且镰状细胞病下降更快。
研究设计与样本
- 多中心观察性队列研究,使用2005年1月至2018年6月注册数据,纳入1251例镰状细胞特质、230例镰状细胞病和8729例正常血红蛋白表型成人黑人患者。
主要发现
- 中位随访8年,校正后镰状细胞特质和镰状细胞病患者eGFR下降均显著快于参照组。
- 镰状细胞病患者eGFR下降显著快于镰状细胞特质患者。
- 男性、糖尿病和基线eGFR≥90 ml/min per 1.73 m2与两种表型更快eGFR下降相关。
- 镰状细胞特质中,低血红蛋白S和高血红蛋白A与更快eGFR下降相关,而高血红蛋白F和A2具肾脏保护作用。
临床怎么用
- 对黑人镰状细胞特质或镰状细胞病患者应关注肾功能下降风险,尤其合并男性、糖尿病或基线eGFR≥90 ml/min per 1.73 m2者。
- 镰状细胞病患者eGFR下降更快,可能需要更密切的肾功能监测。
局限性
- 镰状细胞特质中低血红蛋白S与更快eGFR下降的关联可能受并发血红蛋白病混杂。
- 需前瞻性和机制研究以制定延缓eGFR下降的最佳实践。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sickle cell trait and sickle cell disease are thought to be independent risk factors for CKD, but the trajectory and predictors of kidney function decline in patients with these phenotypes are not well understood. METHODS: Our multicenter, observational study used registry data (collected January 2005 through June 2018) and included adult black patients with sickle cell trait or disease (exposures) or normal hemoglobin phenotype (reference) status (ascertained by electrophoresis) and at least 1 year of follow-up and three eGFR values. We used linear mixed models to evaluate the difference in the mean change in eGFR per year. RESULTS: We identified 1251 patients with sickle cell trait, 230 with sickle cell disease, and 8729 reference patients, with a median follow-up of 8 years. After adjustment, eGFR declined significantly faster in patients with sickle cell trait or sickle cell disease compared with reference patients; it also declined significantly faster in patients with sickle cell disease than in patients with sickle cell trait. Male sex, diabetes mellitus, and baseline eGFR ≥90 ml/min per 1.73 m2 were associated with faster eGFR decline for both phenotypes. In sickle cell trait, low hemoglobin S and elevated hemoglobin A were associated with faster eGFR decline, but elevated hemoglobins F and A2 were renoprotective. CONCLUSIONS: Sickle cell trait and disease are associated with faster eGFR decline in black patients, with faster decline in sickle cell disease. Low hemoglobin S was associated with faster eGFR decline in sickle cell trait but may be confounded by concurrent hemoglobinopathies. Prospective and mechanistic studies are needed to develop best practices to attenuate eGFR decline in such patients.
引用
- Olaniran KO, Allegretti AS, Zhao SH, et al. Kidney Function Decline among Black Patients with Sickle Cell Trait and Sickle Cell Disease: An Observational Cohort Study. J Am Soc Nephrol. 2019. PMID: 31810990. doi:10.1681/ASN.2019050502
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。